NCM
CLB icon

Northwest Capital Management’s Core Laboratories CLB Stock Holding History

Northwest Capital Management’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-30
Closed -$512 – 480
2024
Q1 		$512 Hold
30
– – ﹤0.01% 525
2023
Q4 		$530 Hold
30
– – ﹤0.01% 524
2023
Q3 		$720 Hold
30
– – ﹤0.01% 519
2023
Q2 		$698 Buy
+30
New +$678 ﹤0.01% 522

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Northwest Capital Management's CLB Position: Q2 2024 in Review

Northwest Capital Management sold out of Core Laboratories (CLB) in Q2 2024, closing a stake of 30 shares — an estimated $512 sold.

Northwest Capital Management first reported a position in CLB in Q2 2023 and held it in 4 quarters. The position peaked at $720 in Q3 2023. 194 funds tracked by Wall St. Rank hold CLB as of Q2 2024.

  • Northwest Capital Management reported no remaining Core Laboratories position as of Q2 2024 after selling out during the quarter.
  • Northwest Capital Management sold 30 Core Laboratories shares in Q2 2024, an estimated $512.
  • Northwest Capital Management first reported a position in Core Laboratories in Q2 2023 and held it in 4 quarters.
  • Northwest Capital Management's Core Laboratories position peaked at $720 in Q3 2023.
  • 194 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2024.

Based on Northwest Capital Management's 13F filing for Q2 2024, filed 9 Jul 2024.